ISK

Grant application to support clinical trial for treatment of Alzheimer’s diseaseApril 13, 2021

ISK Ltd and Harvard medical school submitted together grant application to support phase 1B clinical trial for treatment of Alzheimer’s disease.

13 Apr|

ISK attended the 2019 Sachs conference in ZurichMarch 5, 2019

05 Mar|